Phase I trial of fixed dose rate infusion (FDRI) gemcitabine (GEM) with gefitinib in patients with advanced pancreatic carcinoma.

被引：0
|
作者：
Carneiro, B [1 ]
Brand, R [1 ]
Fine, E [1 ]
Knop, R [1 ]
Khandekar, J [1 ]
Uhlig, W [1 ]
Locker, GY [1 ]
机构：
[1] Evanston NW Healthcare, Evanston, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：337S / 337S
页数：1
相关论文
共 50 条
  • [11] Hepatic arterial infusion (HAI) of fixed dose rate gemcitabine in patients with liver metastases from colorectal carcinoma. A phase I study with pharmocokinetic analysis
    Leonard, Gregory D.
    Sperber, Daniella
    O'Connor, Owen
    Kemeny, Nancy E.
    ANNALS OF ONCOLOGY, 2004, 15 : 245 - 245
  • [12] Phase I/II trial of Gemcitabine and Epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A
    Jakobs, R
    Martin, WR
    Riemann, JF
    GASTROENTEROLOGY, 2002, 122 (04) : A493 - A493
  • [13] Phase I/II trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A
    Jakobs, R
    Martin, WR
    Eickhoff, JC
    Riemann, JF
    GASTROENTEROLOGY, 2005, 128 (04) : A432 - A432
  • [14] A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors
    Mortazavi, Amir
    Ling, Yonghua
    Martin, Ludmila Katherine
    Wei, Lai
    Phelps, Mitch A.
    Liu, Zhongfa
    Harper, Erica J.
    Ivy, S. Percy
    Wu, Xin
    Zhou, Bing-Sen
    Liu, Xiyong
    Deam, Deidre
    Monk, J. Paul
    Hicks, William J.
    Yen, Yun
    Otterson, Gregory A.
    Grever, Michael R.
    Bekaii-Saab, Tanios
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 685 - 695
  • [15] A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors
    Amir Mortazavi
    Yonghua Ling
    Ludmila Katherine Martin
    Lai Wei
    Mitch A. Phelps
    Zhongfa Liu
    Erica J. Harper
    S. Percy Ivy
    Xin Wu
    Bing-Sen Zhou
    Xiyong Liu
    Deidre Deam
    J. Paul Monk
    William J. Hicks
    Yun Yen
    Gregory A. Otterson
    Michael R. Grever
    Tanios Bekaii-Saab
    Investigational New Drugs, 2013, 31 : 685 - 695
  • [16] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
    Feliu, J.
    Borrega, P.
    Leon, A.
    Lopez-Gomez, L.
    Lopez, M.
    Castro, J.
    Belda-Iniesta, C.
    Barriuso, J.
    Martinez, V.
    Gonzalez-Baron, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 215 - 221
  • [17] Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
    J. Feliu
    P. Borrega
    A. León
    L. López-Gómez
    M. López
    J. Castro
    C. Belda-Iniesta
    J. Barriuso
    V. Martínez
    M. González-Barón
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 215 - 221
  • [18] Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer
    Tonini, G.
    Vincenzi, B.
    Vasile, E.
    Catalano, V.
    Virzi, V.
    Fontana, A.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Santini, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [19] Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer
    Santini, D.
    Vincenzi, B.
    Masi, G.
    Catalano, V.
    Virzi, V.
    Fontana, A.
    Vasile, E.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [20] PHASE II CAPECITABINE AND GEMCITABINE FIXED DOSE RATE (FDR) IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Santini, D.
    Vincenzi, B.
    Masi, G.
    Catalano, V
    Virzi, V.
    Vasile, E.
    Fontana, A.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 104 - 104
12345